Although no significant changes in insulin sensitivity , inflammation , blood pressure , lipid profile , or HbA@c were found , we observed borderline ( p between @ and @ ) improvements of insulin secretion , in terms of c-peptide levels , first phase incremental AUC insulin and insulin secretory burst mass .